Prostate cancer (PCa) is the second most common cancer in men worldwide (Bray et al., 2018) and most often diagnosed following an elevated prostate-specific antigen (PSA) level (Cooperberg et al., 2005). Here, KLK3 is linked to prostate carcinoma.